Agili-C has demonstrated, in both animal and human studies, an unprecedented ability to regenerate true hyaline cartilage—confirmed by the presence of Type II collagen—without the use of growth factors, stem cells or cell expansion techniques. These results have been confirmed by histological analysis performed by NAMSA, an independent research laboratory.
The Agili-C is CE marked and CartiHeal is currently conducting post-approval clinical studies at leading centers in Europe.
Request Product Information